Date | Insider | Price | Amount |
---|---|---|---|
8-15-2023 Insider Buy |
Vikram Malik Director |
$7.41 CAGR » |
$1,296,505.47 174,967 shares |
1-20-2023 Insider Buy |
Medytox Inc. >10% Owner |
$11.04 CAGR » |
$408,838.67 37,043 shares |
9-7-2022 Insider Buy |
Robert Hayman Director |
$10.05 CAGR » |
$50,250.00 5,000 shares |
9-7-2022 Insider Buy |
Robert Hayman Director |
$10.05 CAGR » |
$49,918.35 4,967 shares |
9-6-2022 Insider Buy |
Simone Blank Director |
$9.24 CAGR » |
$184,844.00 20,000 shares |
9-6-2022 Insider Buy |
Peter C. Farrell Director |
$9.10 CAGR » |
$91,048.00 10,000 shares |
8-27-2021 Insider Buy |
Medytox Inc. >10% Owner |
$10.93 CAGR » |
$557,567.70 51,000 shares |
8-24-2021 Insider Buy |
Medytox Inc. >10% Owner |
$11.10 CAGR » |
$1,576,808.03 142,000 shares |
8-26-2021 Insider Buy |
Medytox Inc. >10% Owner |
$11.06 CAGR » |
$1,216,791.40 110,000 shares |
8-20-2021 Insider Buy |
Medytox Inc. >10% Owner |
$10.53 CAGR » |
$1,084,808.10 103,000 shares |
8-18-2021 Insider Buy |
Medytox Inc. >10% Owner |
$10.63 CAGR » |
$1,222,137.00 115,000 shares |
8-16-2021 Insider Buy |
Medytox Inc. >10% Owner |
$11.18 CAGR » |
$1,282,750.55 114,714 shares |
8-12-2021 Insider Buy |
Medytox Inc. >10% Owner |
$10.87 CAGR » |
$709,451.66 65,286 shares |
6-13-2019 Insider Buy |
David N. Gill Director |
$13.65 CAGR » |
$27,300.00 2,000 shares |
6-3-2019 Insider Buy |
Vikram Malik Director |
$19.25 CAGR » |
$24,999,994.25 1,298,701 shares |
5-29-2019 Insider Buy |
Kristine Romine Director |
$14.77 CAGR » |
$30,863.24 2,090 shares |
5-20-2019 Insider Buy |
Simone Blank Director |
$19.25 CAGR » |
$12,099,318.00 628,536 shares |
5-20-2019 Insider Buy |
Kristine Romine Director |
$19.25 CAGR » |
$780,818.50 40,562 shares |
12-17-2018 Insider Buy |
Vikram Malik Director |
$13.04 CAGR » |
$101,688.60 7,800 shares |
12-14-2018 Insider Buy |
David N. Gill Director |
$12.77 CAGR » |
$38,300.10 3,000 shares |
12-17-2018 Insider Buy |
Kristine Romine Director |
$12.58 CAGR » |
$201,203.80 16,000 shares |
11-29-2018 Insider Buy |
Kristine Romine Director |
$14.00 CAGR » |
$88,858.00 6,347 shares |
11-29-2018 Insider Buy |
Simone Blank Director |
$14.00 CAGR » |
$4,130,336.00 295,024 shares |
9-14-2018 Insider Buy |
Michael M. Jafar Chief Marketing Officer |
$20.83 CAGR » |
$266,590.72 12,800 shares |
8-22-2018 Insider Buy |
Kristine Romine Director |
$19.83 CAGR » |
$198,270.00 10,000 shares |
6-14-2018 Insider Buy |
Vikram Malik Director |
$28.88 CAGR » |
$248,353.38 8,600 shares |
6-6-2018 Insider Buy |
Bosun Hau Director |
$34.94 CAGR » |
$101,255.83 2,898 shares |
6-4-2018 Insider Buy |
Bosun Hau Director |
$29.19 CAGR » |
$208,471.41 7,142 shares |
6-1-2018 Insider Buy |
Kristine Romine Director |
$25.16 CAGR » |
$176,148.00 7,000 shares |
6-8-2018 Insider Buy |
Kristine Romine Director |
$28.54 CAGR » |
$62,780.00 2,200 shares |
Also See: Institutional Holders of EOLS
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 08/16/2023 | |
End date: | 04/18/2024 | |
Start price/share: | $10.20 | |
End price/share: | $11.56 | |
Dividends collected/share: | $0.00 | |
Total return: | 13.33% | |
Annualized Gain: | 19.78% | |
Starting investment: | $10,000.00 | |
Ending investment: | $11,333.00 | |
Years: | 0.67 |
EOLS Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent EOLS insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding EOLS
Free EOLS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the EOLS Insider Buying occurred are:
HR Insider Buying |